Testing GLP-1 Drugs for Substance Use Disorders
Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.
A New Book Makes The Case That Addiction Is Not a Brain Disease
A new book and a new brain study are raising doubts about addiction as a chronic brain condition.
Does Ozempic Cause Weight Loss By Making People Sick?
We examine anecdotal reports and scientific evidence concerning gastrointestinal discomfort as a result of taking GLP-1 drugs.
Why Isn’t Big Pharma Investing in GLP-1 Trials for Substance Use Disorders?
There’s a noticeable lack of pharmaceutical company trials of GLP-1 drugs as treatments for substance use disorders.
Is Ozempic the Gateway Drug for CBT?
Two recent studies show nearly twice the weight loss for patients who undergo group CBT in addition to taking liraglutide, a GLP-1 agonist.
A Pathway Out of Addiction?
Could a wearable ultrasound device be a pathway out of addiction, or even a way to prevent it?